Back to results
US 12,564,601 B2Granted
Methods for treating hepatitis B infection
AssigneeDicerna Pharmaceuticals, Inc.
InventorsMartin Koser, Marc Abrams
Life of this patent
Estimating the term…
Abstract
This application relates to potent oligonucleotides useful for reducing HBsAg expression and treating HBV infections.
Claims23
An oligonucleotide comprising an antisense strand, wherein the antisense strand consists of a sequence as set forth in UUAUUGUGAGGAUUUUUGUCGG (SEQ ID NO:
- 6), which comprises
- 2′-fluoro modified nucleotides at positions 2, 3, 5, 7, 8, 10, 12, 14, 16, and 19;
- 2′-O-methyl modified nucleotides at positions 1, 4, 6, 9, 11, 13, 15, 17, 18, and 20-22;
- and
- phosphorothioate linkages between nucleotides at positions 1 and 2, between nucleotides at positions 2 and 3, between nucleotides at positions 3 and 4, between nucleotides at positions 20 and 21, and between nucleotides at positions 21 and 22,
- wherein the 5′-nucleotide of the antisense strand has the following structure:
3 more elements
Dependencies are inferred from the claim text.